(Reuters) - "This is excellent news," Zeltia Chairman Jose Maria
Fernandez Sousa said in a statement.
"Under the expected timeframe, many European patients may
have access to Yondelis before the end of the year," added
Zeltia.
Read more at Reuters.com Government Filings News
Fernandez Sousa said in a statement.
"Under the expected timeframe, many European patients may
have access to Yondelis before the end of the year," added
Zeltia.
Read more at Reuters.com Government Filings News
No comments:
Post a Comment